These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 32773788)

  • 1. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].
    Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy.
    Liu L; Xie W; Song Z; Wang T; Li X; Gao Y; Li Y; Zhang J; Guo X
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):132-138. PubMed ID: 34486152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X
    Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma.
    Bílek R; Vlček P; Šafařík L; Michalský D; Novák K; Dušková J; Václavíková E; Widimský J; Zelinka T
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31027285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma.
    Wang K; Gao X; Cong H; Zhang W; Shi X; Dai S; Zhou Z
    Endocrine; 2020 Jul; 69(1):188-195. PubMed ID: 32222878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases.
    Kawashima A; Sone M; Inagaki N; Okamoto K; Tsuiki M; Izawa S; Otsuki M; Okamura S; Ichijo T; Katabami T; Takeda Y; Yoshimoto T; Naruse M; Tanabe A
    Endocrine; 2021 Oct; 74(1):155-162. PubMed ID: 34272648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
    Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
    Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of reference intervals for plasma metanephrines in seated position measured by LC-MS/MS and assessment of diagnostic performance in pheochromocytoma/paraganglioma.
    Lin Y; Wang M; Cao Y
    Ann Clin Biochem; 2023 May; 60(3):160-168. PubMed ID: 36653315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of duration of preoperative treatment with phenoxybenzamine and secretory phenotypes on perioperative hemodynamics and postoperative outcomes in pheochromocytoma and paraganglioma.
    Yao Y; Guo Y; Fan J; Lin T; Wang L; Zhang S
    Front Endocrinol (Lausanne); 2023; 14():1139015. PubMed ID: 37152936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma.
    Eisenhofer G; Peitzsch M; Bechmann N; Huebner A
    Front Endocrinol (Lausanne); 2022; 13():901760. PubMed ID: 35957826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of Plasma-Free Metanephrines by Immunoassay Versus Urinary Metanephrines and Catecholamines by Liquid Chromatography with Amperometric Detection for the Diagnosis of Pheochromocytoma/Paraganglioma.
    Raber W; Kotal H; Marculescu R; Scheuba C; Niederle MB; Kautzky-Willer A; Krebs M
    J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32993074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
    Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
    Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Metanephrines Yield Fewer False-Positive Results Than Urine Metanephrines in Patients With Obstructive Sleep Apnea.
    King TFJ; Mok Y; Dacay LM; Wong HS; Hsu PP; Tan A; Wong KM; Saffari SE; Lenders JWM; Puar TH
    J Clin Endocrinol Metab; 2024 Feb; 109(3):844-851. PubMed ID: 37721483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
    Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
    Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
    Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
    J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
    Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
    Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
    Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Levels of Catecholamines and Metanephrines and Intraoperative Hemodynamics of Patients Undergoing Pheochromocytoma and Paraganglioma Resection.
    Weingarten TN; Welch TL; Moore TL; Walters GF; Whipple JL; Cavalcante A; Bancos I; Young WF; Gruber LM; Shah MZ; McKenzie TJ; Schroeder DR; Sprung J
    Urology; 2017 Feb; 100():131-138. PubMed ID: 27769919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.